Cite
HARVARD Citation
Lik Yuen Chan, H. et al. (n.d.). IDDF2019-ABS-0168 Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF). Gut. p. A141. [Online].